Sponsor pipeline

Ohio State University Comprehensive Cancer Center clinical trial pipeline

Get alerts when Ohio State University Comprehensive Cancer Center's trials change

111 active trials 68 recruiting 32 disease areas 24 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-10-01
Primary completion pushed: 2026-07-31 → 2027-07-31
Completion pushed: 2026-07-31 → 2027-07-31
NCT06630429 A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
2026-09-25
Primary completion pushed: 2026-08-15 → 2027-02-15
Completion pushed: 2026-08-15 → 2027-02-15
NCT02940301 Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical… · Phase 2
2026-09-25
Primary completion pushed: 2026-06-18 → 2027-04-18
Completion pushed: 2026-06-18 → 2027-04-18
NCT05717998 Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury…
2026-09-10
Primary completion pushed: 2026-12-31 → 2027-05-31
Completion pushed: 2026-12-31 → 2027-05-31
NCT04049539 Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent… · Phase 1/2
2026-09-29
Trial completed
Study completion confirmed: April 2026 (last estimated December 2026)
NCT07144384 Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and… · Early Phase 1
2026-09-29
Trial completed
Final enrollment: 116 participants (planned 157)
NCT06396598 Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With…
2026-09-26
Trial completed
Final enrollment: 7 participants (planned 25)
Primary completion confirmed: May 2026 (last estimated June 2026)
NCT07149220 Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults… · Phase 1
2026-09-25
Recruitment opened
NCT07564648 Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability
2026-09-04
Recruitment opened
NCT07780838 Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or… · Phase 2
2026-09-16
Enrollment reopened
NCT04780568 Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic… · Phase 1
2026-09-16
Enrollment closed, study ongoing
Final enrollment: 33 participants (planned 30)
NCT07455513 A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic…
2026-09-10
Trial completed
Study completion confirmed: June 2025 (last estimated December 2027)
NCT05869318 Respiratory Effects of E-Cigarettes in Obese Youth
2026-09-03
Trial completed
Study completion confirmed: October 2025 (last estimated December 2026)
NCT03719092 High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor…

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-23 NCT07835841 Blessing Stem Cells to Improve Spiritual Well Being and Quality of Life for Patients… Not Yet Recruiting
2026-09-16 NCT07823491 Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and… Phase 3 Not Yet Recruiting
2026-09-03 NCT07802054 Messages That Motivate: Communicating Alcohol-Related Breast Cancer Risk to Young Adult… Not Yet Recruiting

Active trials by phase

Early Phase 1
4
Phase 1
8
Phase 1/2
3
Phase 2
14
Phase 3
1
Phase 4
3
Not charted: 78 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 111

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07503925 THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health Tobacco-Related Carcinoma Recruiting 2026-08-17
NCT07474519 Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette… Non-Muscle Invasive Bladder Carcinoma Recruiting 2026-03-16
NCT06630728 Addiction Potential of Very Low Nicotine Filtered Little Cigars Smoking (Tobacco) Addiction Recruiting 2025-10-16
Phase 3
NCT07823491 Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and… Resectable Liposarcoma Not Yet Recruiting 2026-09-16
Phase 2
NCT07780838 Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or… Locally Advanced Ampulla of Vater Carcinoma Recruiting 2026-09-10
NCT06315881 Informing Oral Nicotine Pouch Regulations to Promote Public Health Tobacco-Related Carcinoma Recruiting 2026-08-17
NCT07529483 Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic… Pancreatic Cystic Neoplasm Recruiting 2026-05-29
NCT07407647 Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal… Anal Carcinoma Recruiting 2026-04-21
NCT06323460 Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated… Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Recruiting 2026-03-24
NCT06223659 EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99… Cutaneous Melanoma Recruiting 2026-03-10
NCT06330805 Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer Prostate Adenocarcinoma Recruiting 2026-03-09
NCT05336812 Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of… Chronic Lymphocytic Leukemia Recruiting 2026-02-19
NCT06749210 DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY Cancer of the Breast Recruiting 2025-11-05
NCT02940301 Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical… Classical Hodgkin Lymphoma Active, Not Recruiting 2026-09-24
NCT07594678 Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced… Anatomic Stage I Breast Cancer AJCC v8 Not Yet Recruiting 2026-09-02
NCT02927912 Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II… Stage IA Breast Cancer Active, Not Recruiting 2026-06-03
NCT03513562 Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia… Chronic Lymphocytic Leukemia Active, Not Recruiting 2026-02-06
NCT05503251 Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in… Metastatic Malignant Neoplasm in the Brain Active, Not Recruiting 2025-12-24
Phase 1/2
NCT04049539 Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent… Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Recruiting 2026-09-09
NCT07705919 DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable… Borderline Resectable Pancreatic Ductal Adenocarcinoma Not Yet Recruiting 2026-07-15
NCT07217990 Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of… Breast Cancer Not Yet Recruiting 2026-06-24
Phase 1
NCT04780568 Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic… Metastatic Lung Non-Small Cell Carcinoma Recruiting 2026-09-15
NCT04754321 Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer Head and Neck Carcinoma of Unknown Primary Recruiting 2026-07-24
NCT06741072 BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus… Chronic Kidney Disease, Stage 4 Recruiting 2026-07-02
NCT05136846 Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small… Locally Advanced Lung Non-Small Cell Carcinoma Recruiting 2026-06-30
See all 111 active Ohio State University Comprehensive Cancer Center trials with filters →

Disease areas by active trials, top 10 of 32

Breast Cancer (24) · Lung Cancer (8) · Non-Small Cell Lung Cancer (NSCLC) (8) · Pancreatic Cancer (6) · Leukemia (5) · Cervical Cancer (4) · Head & Neck Cancer (4) · Chronic Lymphocytic Leukemia (CLL) (3) · Colorectal Cancer (3) · Melanoma (3)

Get alerts when Ohio State University Comprehensive Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free